2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - (Page 9) medications studies; and 3) Discuss the place "placebo" has in medical treatment. 14-3 New Clinical Research with Psychedelic Drugs AP 13-2 Do Antidepressants Increase the Risk of Suicide? CA PD About 5% of adolescents suffer from depression and suicide is the third leading cause of death in the US for ages 10 through 24. The introduction of a safer generation of antidepressants (e.g., SSRIs; SNRIs) led to their widespread use and correlated with a decrease in the suicide rate in this age group. More recently, however, the FDA mandated a boxed warning for all antidepressants due to concerns about an increased risk for “suicidality” with these agents when compared to placebo in controlled trials. The results of this action on drug treatment of depression and the impact on suicide rates will be discussed. By participating in this activity, attendees will be able to: 1) Analyze the data from the FDA and independent investigators’ reviews regarding this risk of suicidality; 2) Describe the possible differential impact of these agents on suicide across the life cycle; and 3) Formulate an appropriate strategy to treat depression and suicidality in younger age groups. After a 40-year research hiatus, psychedelic drugs are once again being examined for their clinical usefulness. Recent careful systematic studies show that these and related compounds have promise for the treatment of depression, and preliminary studies suggest their usefulness in the management of terminal illness, OCD, cluster headache and addictions. By participating in this activity, attendees will be able to: 1) Describe the effects of ketamine in depression; 2) Discuss the evidence for the usefulness of psychedelic drugs in the treatment of alcohol dependence; and 3) Explain the mechanisms by which psychedelic drugs may alleviate the suffering of the terminally ill. self-image, obesity, eating disorders); 2) Discuss the impact of television programming on children and teens and how such effects were determined by research; and 3) Identify how the adverse effects of TV and other media can be mediated by parents and by school media literacy programs. 16-2 Drug-Induced Movement Disorders RX 15-0 15-1 Insomnia Dealing with Career Frustration: How to Create Job Fulfillment, Free Up Personal Time and Maximize Revenue PI Drug-induced movement disorders present a unique challenge for neuroscience practitioners. By participating in this activity, attendees will be able to: 1) Discuss the pathophysiology of drug-induced movement disorders; 2) Recognize the classes of drugs that are known to affect central dopaminergic systems and cause drug-induced movement disorders; and 3) Identify the risk factors, management and prognosis for drug-induced movement disorders. 16-3 Systems Neuropsychiatry, Part 1: The Decade of the Mind NP 13-3 A Busy Clinician’s ‘Treasure Chest’: Creating a Tool Box Filled with Screeners and Rating Instruments to Improve Patient Outcomes PI Both psychiatric and nonpsychiatric clinicians tend to underutilize screeners and rating instruments in their busy practices. This is an error worth rectifying expeditiously for the following reasons: use of screeners and rating instruments can actually improve outcomes, it can be very time efficient and many quality tools are available for no charge. This workshop will show videos of a few clinical scenarios and discuss what tools might have been appropriate to use. Copies of noncopyrighted screeners and rating instruments, appropriate for both psychiatric and nonpsychiatric settings, will be made available to participants. A toolkit filled of screeners and rating instruments will be brought to the workshop to show participants how they can create one for their own use. By participating in this activity, attendees will be able to: 1) Recognize the many noncopyrighted tools available for clinician use covering a range of psychiatric disorders; 2) Define these tools that are very time efficient and improve diagnostic yield; and 3) Describe how to choose the right tool and how to score them. The practice of psychiatry can be a source of both great satisfaction and great stress. By participating in this activity, attendees will be able to: 1) Identify professional goals; 2) Recognize the steps for recovering from burnout and avoiding burnout altogether; and 3) Discuss the management of careerspecific stressors, and how they can achieve balance between their personal and professional lives to maximize satisfaction. 15-2 Cognitive Therapy for Depression: Where It Began—An Update PD PT This course will trace the evolution of the cognitive therapy model for treating depression. It will define and describe cognitive therapy, then illustrate a typical session and present several successfully treated cases. By participating in this activity, attendees will be able to: 1) Explain how cognitive therapy has become one of psychotherapy’s major treatment modalities for depression; 2) Describe the range and creativity encompassed by the cognitive model for the clinician treating depression; and 3) Apply a cognitive framework for depression to a group of patients, and also to a clinician’s own patients. 15-3 Ooh, Baby, Baby: Adolescents, Sex and the Media PI HOT! Ten prominent neuroscientists, one of them a psychiatrist, proposed in a Fall 2007 letter in Science magazine that the years 2010-2020 be devoted to a paradigm-shifting, major national research initiative: “The Decade of the Mind.” Others have asked for a coordinated international effort. Beginning with the stunning assertion that “A deep scientific understanding of how the mind perceives, thinks, and acts is within our grasp,” the Science proposal spans disparate fields such as cognitive science, medicine, neuroscience, psychology, mathematics, engineering, and computer science, with additional important insights from systems biology, cultural anthropology, social science, robotics and automation technology. For psychiatry, the implications are vast and hardly tapped, and they will be introduced in this two part seminar. Part 1 will focus upon the foundational base that cognitive neuropsychiatry affords clinical practice in the upcoming “Decade of the Mind.” By participating in this activity, attendees will be able to: 1) Describe the proposed 2010 – 2020 “Decade of the Mind," a decade that will radically transform the way in which we promote mental health and understand and treat psychiatric disorders; 2) Identify the four pivotal, intertwined domains to be focused upon in the undertaking (healing and protecting, understanding, enriching and modeling the mind); and 3) Incorporate this knowledge into daily practice. 11:00 a.m.-12:15 p.m 14-0 Major Depressive Disorder 14-1 Supported in part by an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. Libby Zion's Lesson: Serotonin Syndrome and P450 Drug Interactions RX This course discusses common drug-drug interactions that physicians face in clinical practice. By participating in this activity, attendees will be able to: 1) Identify the most common mechanisms underlying drug-drug interactions; 2) Describe common drug-drug interactions affecting U.S. Food and Drug Administration–approved agents and detail dose adjustments where appropriate; and 3) Discuss the recommendations on how to resolve contraindications or manage interactions. Do the media merely "reflect" the real world–as Hollywood and network executives would have us believe–or do they cause real-life problems as well? Do the media contribute to early sexual intercourse? Could the media increase teens’ use of contraception? This talk will try to illuminate what we know about the impact of the media on adolescents, what we don't know, and what we need to do to find out. Several suggestions for parents and for schools will be presented. By participating in this activity, attendees will be able to: 1) Describe the nature of current television programming for adolescents; 2) Discuss the impact of television programming on children and teens and how such effects were determined by research; and 3) Identify how the adverse effects of TV and other media can be mediated by parents and by school media literacy program. 1:15-3:15 p.m. 16-4 Young Clinicians Forum PI 2.0 Credits I’m a doctor – now what do I do? Medical schools provide quality education, but do not offer real life practical information on the many scenarios facing young clinicians today. This interactive roundtable discussion offers the opportunity to gain insight from seasoned professionals on a variety of pertinent issues. By participating in this activity, attendees will 1) Demonstrate a deeper understanding of the business and practice aspects of medicine through sharing and networking with peers; 2) Discuss and explore practice issues affecting young clinicians; and 3) Discover how to equip themselves to respond effectively and prepare for the future as health care professionals. 12:30-2:30 p.m. 16-0 Schizophrenia 14-2 A Biopsychosocial Approach to Pathological Gambling GP PI HOT! Lunch Symposium • 1.5 credits 2:45-4:00 p.m. 17-1 The Neurobiology of Empathy GP The activation of mirror neurons has been shown to mediate complex human behaviors, from active empathy to the perception of other people's motivational states (Theory of Mind). By participating in this activity, attendees will be able to: 1) Explore the biology of this fascinating group of neurons; 2) Speculate how such knowledge potentially provides an impact to modern psychiatry; and 3) Discuss the theories that integrate behavioral, affective and cognitive elements of empathy. The current poker "craze" has led to an increase in the incidence of pathological gambling in multiple epidemiologic sectors of the United States. As such, it is more important than ever for mental health experts to be familiar with the diagnosis, evaluation and treatment of this disorder. By participating in this activ
Table of Contents Feed for the Digital Edition of 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 U.S. Psychiatric & Mental Health Congress Conference & Exhibition Exhibit Hall Opportunities Contents Industry-Supported Symposia Educational Track System Educational Sessions Hosts and Advisory Committee Faculty Presenters About San Diego Discounted Tax-Deductible Tuition 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - U.S. Psychiatric & Mental Health Congress Conference & Exhibition (Page 1) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - U.S. Psychiatric & Mental Health Congress Conference & Exhibition (Page 2) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - U.S. Psychiatric & Mental Health Congress Conference & Exhibition (Page 3) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Contents (Page 4) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Industry-Supported Symposia (Page 5) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Track System (Page 6) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Track System (Page 7) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 8) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 9) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 10) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 11) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 12) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 13) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 14) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 15) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Educational Sessions (Page 16) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Hosts and Advisory Committee (Page 17) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Hosts and Advisory Committee (Page 18) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Faculty Presenters (Page 19) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Faculty Presenters (Page 20) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Faculty Presenters (Page 21) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - About San Diego (Page 22) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Discounted Tax-Deductible Tuition (Page 23) 2008 U.S. Psychiatric & Mental Health Congress Conference & Exhibition brochure #4 - Discounted Tax-Deductible Tuition (Page 24)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.